Pharmaceutical Industry Reports Ferrous Fumarate Market – Industry Size, Share, Tr | Page 2

REPORT DESCRIPTION
Ferrous Fumarate Market – Overview
Increasing prevalence of anemia and thalassemia is expected to boost growth of the global ferrous fumarate
market. Anemia is a condition characterized by lack of red blood cells to carry adequate oxygen to the body's
tissues. Women in the childbearing years are highly vulnerable to anemia and iron-deficiency. Ferrous fumarate
tablets can be consumed orally and are easy to swallow. These tablets can be crushed or chewed as they are almost
tasteless. It acts as an iron supplement to treat or prevent low blood levels of iron.
However, there are many restrictions in use of ferrous fumarate. Ferrous fumarate is not recommended to those
suffering from liver or kidney disease and porphyria. Consuming ferrous fumarate is also associated with some
side effects such as constipation, black stool, stomach pain, abdominal bloating, flatulence, and abdominal pain.
Ferrous fumarate is the iron (II) salt of fumaric acid used for the prevention and treatment of iron-deficiency
anemias. It is used as a dietary supplement and its administration results in elevation of serum iron concentration,
which is then assimilated into hemoglobin. Hemoglobin carries oxygen through blood to tissues and organs.
Ferrous fumarate is used for the treatment of thalassemia, iron deficiency anemia, fatigue, and anemia. It is also
used for diagnostic assessment.